Lettmann Jason 4
4 · ALX ONCOLOGY HOLDINGS INC · Filed Mar 18, 2025
Insider Transaction Report
Form 4
Lettmann Jason
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Award
Common Stock
2025-03-14+42,000→ 212,270 total
Footnotes (1)
- [F1]The reported shares are represented by performance share units, or PSUs, and were awarded upon the achievement of certain performance metrics related to the positive results for ASPEN-06 clinical trials. Shares subject to the PSU vest on March 14, 2026.